Stämm
Stämm makes biomanufacturing easier and more scalable by providing an automated, continuous bioreactor platform for producing biologics and cell therapies. Their core product, the Bioprocessor, is a plug-and-play continuous bioreactor that enables automated production runs of up to 90 days and improves process repeatability and productivity. In addition to hardware, Stämm offers end-to-end bioengineering services and Bio AI capabilities using AI, multi-omics data, and generative models to build cell-predictive pipelines and optimize cell line development. The company operates globally with facilities in the USA, Argentina, and Switzerland and serves companies in the biologics and cell therapy sectors.
Stämm
Stämm makes biomanufacturing easier and more scalable by providing an automated, continuous bioreactor platform for producing biologics and cell therapies. Their core product, the Bioprocessor, is a plug-and-play continuous bioreactor that enables automated production runs of up to 90 days and improves process repeatability and productivity. In addition to hardware, Stämm offers end-to-end bioengineering services and Bio AI capabilities using AI, multi-omics data, and generative models to build cell-predictive pipelines and optimize cell line development. The company operates globally with facilities in the USA, Argentina, and Switzerland and serves companies in the biologics and cell therapy sectors.